MoneyWorks4Me

The company witnessed a 6.86% growth in the revenue at Rs. 15803.50 millions for the quarter ended September 2024 as compared to Rs. 14788.40 millions during the year-ago period.A humble growth in net profit of 23.86% reported in the quarter ended September 2024 to Rs. 1657.80  millions from Rs. 1338.40 millions.The company reported a good operating profit of 2755.50 millions compared to 2164.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 15803.50 14788.40 6.86 30559.10 28111.10 8.71 58740.60 51490.00 14.08
Other Income 160.60 89.50 79.44 192.00 208.00 -7.69 313.20 35.40 784.75
PBIDT 2755.50 2164.10 27.33 5701.20 3939.80 44.71 10298.40 6678.80 54.20
Interest 182.80 153.90 18.78 309.70 296.80 4.35 544.70 490.00 11.16
PBDT 2701.40 2010.20 34.38 5520.20 3643.00 51.53 9753.70 6188.80 57.60
Depreciation 701.20 671.80 4.38 1388.00 1329.30 4.42 2711.40 2729.50 -0.66
PBT 2000.20 1338.40 49.45 4132.20 2313.70 78.60 7042.30 3459.30 103.58
TAX 342.40 0.00 0.00 712.50 0.00 0.00 377.50 -8.00 -4818.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1657.80 1338.40 23.86 3419.70 2313.70 47.80 6664.80 3467.30 92.22
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 17.44 14.63 19.15 18.66 14.02 33.12 17.53 12.97 35.16
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..